Unifocalization and repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries.

AIM To correlate anatomic and genetic features of paediatric patients with pulmonary atresia, ventricular septal defect (VSD) and multiple aortopulmonary collateral arteries with surgical outcome. METHODS 44 consecutive patients aged 33 +/- 40 mo underwent either primary one-stage unifocalization (n = 32) or palliative right ventricular outflow tract reconstruction (n = 12) followed by secondary unifocalization and repair (n = 10) based on preoperative morphometric and functional evaluation of pulmonary blood sources. Chromosome 22q11.2 microdeletion occurred in 41% of cases. Combined VSD closure during one-stage procedures was guided by an intraoperative pulmonary flow study. Complete repair was accomplished in 35 cases (83%, 95% CI 72-95%). Variables examined included occurrence of confluent intrapericardial pulmonary arteries, central pulmonary arteries, confluent intraparenchymal pulmonary arteries, dominant collateral or pulmonary arteries, and chromosome 22q11.2 microdeletion. The sensitivity and specificity of the pulmonary flow study in predicting postoperative pulmonary haemodynamics were also tested. RESULTS Eight-year actuarial survival and freedom from reoperation were 85% and 63%, respectively. Sensitivity and specificity of the pulmonary flow study were 94% and 100%, respectively. None of the anatomical variables examined was significantly related to the outcome of treatment. The only statistically relevant association was detected between survival and occurrence of 22q11.2 microdeletion (p < 0.003). Logistic analysis showed an increased likelihood of positive outcome in relation to first- (p < 0.02) or second-stage (p < 0.04) complete correction. CONCLUSION Morphology of pulmonary blood supply has no major impact on surgical outcome. Pulmonary flow study is a highly specific and sensitive intraoperative test. Chromosome 22q11.2 microdeletion remains the only variable significantly affecting survival.

[1]  David J Barron,et al.  The influence of pulmonary artery morphology on the results of operations for major aortopulmonary collateral arteries and complex congenital heart defects. , 2004, The Journal of thoracic and cardiovascular surgery.

[2]  B. Marino,et al.  Influence of chromosome 22q11.2 microdeletion on surgical outcome after treatment of tetralogy of fallot with pulmonary atresia. , 2003, The Journal of thoracic and cardiovascular surgery.

[3]  L. Latson,et al.  Staged repair of tetralogy of Fallot with pulmonary atresia and major aortopulmonary collateral arteries. , 2003, The Journal of thoracic and cardiovascular surgery.

[4]  G. Minniti,et al.  Increasing experience with integrated approach to pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  D. McElhinney,et al.  Early and intermediate outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries: experience with 85 patients. , 2000, Circulation.

[6]  R. D. Di Donato,et al.  Total repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals: an integrated approach. , 1998, The Journal of thoracic and cardiovascular surgery.

[7]  A. Munnich,et al.  Relation of genotype 22q11 deletion to phenotype of pulmonary vessels in tetralogy of Fallot and pulmonary atresia–ventricular septal defect , 1998, Heart.

[8]  D. McElhinney,et al.  One-stage complete unifocalization in infants: when should the ventricular septal defect be closed? , 1997, The Journal of thoracic and cardiovascular surgery.

[9]  F. Hanley,et al.  Midline one-stage complete unifocalization and repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collaterals. , 1995, The Journal of thoracic and cardiovascular surgery.